Insights
Insights From Our Experts
Articles
Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets
Are you interested in the latest developments in high-cost drug reforms across the EU4+UK markets? Our comprehensive paper, “Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets,” delves into the intricate landscape of pharmaceutical pricing and…
Navigating India’s Rapidly Growing Obesity Market
Authors: Monica Gangwani, Executive Director India, Advisory Services, APAC Consulting; Gaurav Kolhekar, Senior Consultant, APAC Consulting; Utkarsh Sahu, Analyst, APAC Consulting India’s obesity market is rapidly expanding, driven by economic growth and lifestyle changes that have…
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
In today’s healthcare landscape, patients are no longer passive recipients of care. They are empowered, tech-savvy stakeholders who demand efficiency and transparency. Yet, despite advancements in consumer innovation, the healthcare system often leaves them frustrated with…
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Are you interested in the rapidly evolving pharmaceutical landscape? Do you want to understand the paradigm shift in global commercialization strategies? If so, we have just the resource for you! Download our latest article titled “The…
The Omnichannel Landscape in APAC’s Healthcare Industry
As the pharmaceutical industry in the Asia-Pacific (APAC) region undergoes a digital transformation, the shift towards an omnichannel strategy is reshaping how companies engage with healthcare professionals (HCPs). “The Omnichannel Landscape in APAC’s Healthcare Industry,” authored…
EVERSANA Experts On-Stage at Frontiers Health 2024
In anticipation of Frontiers Health 2024, EVERSANA is delighted to reveal that several of our key experts will be speaking at this top-tier global health innovation conference! Scheduled for October 17-18th in Berlin, Germany, Frontiers Health…
Canadian Market Access Success Starts With the Right Partner
The Canadian market access and reimbursement environment is in an era of unprecedented change. HTA bodies are transforming their organizations to make review processes more efficient and give Canadians faster access to new drugs (e.g., Target…
Can the Mobile Wave Help Us Navigate the AI Wave?
Tech experts from Wharton and Forrester look back on the advent of the iPhone, identifying key lessons that leaders today can apply to AI. The following article was written by Scott A. Snyder, a senior fellow at…
EVERSANA’s Predictive Analytics: A Capabilities Compendium
In the fast-changing world of healthcare, machine learning (ML) and real-world evidence (RWE) bring us closer to the goal of precision medicine: delivering the right treatment to the right patient by the right physicians at the…
National Institutes of Health Taps EVERSANA for Research on the Impact of Rare Disease on Patients, Healthcare System
The National Institutes of Health (NIH) has selected EVERSANA, a leading service provider to the life sciences industry, to conduct the next phase of research on the impact of rare diseases on patients and the overall…